Profile: American Oriental Bioengineering, Inc. (AOB)

American Oriental Bioengineering, Inc. (AOB) is an integrated, pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. The Company’s business comprises prescription pharmaceutical products, over-the-counter (OTC) pharmaceutical products and nutraceutical products. Its pharmaceutical products have been approved by the Chinese State Food and Drug Administration (SFDA). The Company sells its products primarily to hospitals, clinics, pharmacies and retail outlets at over 100,000 locations in all provinces, including rural areas and cities in China. During the year ended December 31, 2008, AOB marketed over 60 pharmaceutical products in China. On October 18, 2008, the Company acquired Nuo Hua Investment Company Limited. On October 20, 2008, the Company acquired GuangXi HuiKe Pharmaceutical Research and Development Co., Ltd.

Prescription Pharmaceutical Products

The Company’s Shuanghuanglian Lyophilized (SHL) Injection Powder is a prescription pharmaceutical product approved and marketed for the treatment of flu symptoms, including high fever, cough and sore throat, as well as upper respiratory infections, mild pneumonia and tonsillitis. The SHL Injection Powder is marketed under the name SHJ. The approved dosage for its SHL Injection Powder is 60 milligram for every kilogram of a patient’s body weight.

AOB’s Cease Enuresis (CE) Soft Gel is a prescription pharmaceutical product approved and marketed to alleviate pediatric bedwetting. This product consists of a formulation that is isolated from the seed of a plant. This product is manufactured at its Three Happiness facility in Harbin.

Over-the-Counter Pharmaceutical Products

CE Patch is an OTC pharmaceutical product approved and marketed for the treatment of bedwetting and incontinence. Its CE Patch is formulated for delivery by a patch and can be used in combination with CE Gel. This product consists of the same plant based ingredients as its CE Gel. This product is manufactured at its Three Happiness facility. The Company’s Jinji Capsule is an OTC pharmaceutical product approved and marketed for the treatment of endometritis, annexitis and pelvic inflammations. This product consists of a combination of many parts of Traditional Chinese Medicine (TCM) plants, including roots, vines, flowers and stems.

Jinji Yimucao is an OTC pharmaceutical product approved and marketed for the treatment of premenstrual syndrome (PMS), and other PMS and menopause-related symptoms. This product consists of a combination of many parts of TCM plants, including roots, vines, flowers and stems. Each treatment requires a dose of two packets of powder for oral suspension taken two times a day.

Boke nasal spray is an OTC pharmaceutical product approved and marketed for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis and nasosinusitis. The spray is marketed under the product name of Ditong Biyanshui Penwuji (Ditong). This product consists of a combination of many parts of TCM plants, including roots, vines, flowers and stems. Treatment dosage is three to four times a day and two sprays into each nostril.

Nutraceutical Products

Soy Peptide Series is the Company’s primary line of nutraceutical products, all of which are available in supermarkets, fitness centers, specialty nutraceutical stores and other retail outlets. These products include tablets, powders, drinks and instant coffee that are non-genetically modified and derived from soybeans through a biochemical process involving decomposition, conversion and synthesis of soybean protein. They are used as food and beverage supplements. The Company has four formulations: anti-fatigue, menopause, immunoenhancer and balanced formula. It manufactures these products at its Three Happiness facility in Harbin.

The Company competes with Harbin Pharmaceutical Group, Shangdong Zhiling Pharmaceutical Company, Tianjin Zhongxin Company, Shanxi Dingxing Healthcare Scientific Limited, Jilin Tianguang Pharmaceutical Limited, Huahong Pharmaceutical Group, Qianjin Pharmaceutical Group, Guangdong Foshan Dezhong Pharmaceutical Co., Ltd, Wuhan Zhonglian Pharmaceutical Co., Ltd, Guangzhou Qixing Pharmaceutical Co., Ltd, Leneng Bioengineering Company and Harbin High-Tech Company Limited.